Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Boardmarketbeat.com
Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to the company’s auditor, board size, corporate name and director elections. Eric So, the company’s co-founder and executiv
Via MarketBeat · September 22, 2026
QuantaSing Group Q4 Earnings Call Highlightsmarketbeat.com
Here Group reported fourth-quarter revenue of CNY127.7 million for fiscal 2026, an increase of 94.1% from a year earlier, as sales of existing and newly launched pop-toy intellectual property products rose. Full-year revenue reached CNY596.8 million, according to Founder, Chairman and Chief Executiv
Via MarketBeat · September 22, 2026
The Fed Just Gave Berkshire a Raise. Here’s How Big It Is.fool.com
Berkshire’s $365 billion in cash is a valuable asset in a rising-rate environment.
Via The Motley Fool · September 22, 2026
Strategy's Stock Has Soared 40% in the Past Month as It's Buying Bitcoins Againfool.com
The tech stock has benefited from Bitcoin's rising value of late.
Via The Motley Fool · September 22, 2026
EZCORP INC-CL A (NASDAQ:EZPW): Affordable Growth at a Reasonable Valuationchartmill.com
Via Chartmill · September 22, 2026
Cybersecurity Rally’s Narrow Leadership Leaves Profitable Value Names Behindchartmill.com
Via Chartmill · September 22, 2026
DoorDash Chief Business Officer Keith Yandell Sells 2,184 Sharesfool.com
Yandell disposed of stock worth $438,460 under a pre-established trading plan, while maintaining a direct holding of 120,688 shares valued.
Via The Motley Fool · September 22, 2026
Prediction: Broadcom Will Be a $3 Trillion Company by the End of 2030fool.com
Management's own revenue forecasts could carry the stock there without a richer earnings multiple.
Via The Motley Fool · September 22, 2026
MongoDB Director Hope Cochran Sells 1,000 Sharesfool.com
Insider executed a sale under a pre-arranged trading plan, retaining a stake worth ~$11 million.
Via The Motley Fool · September 22, 2026
Despite Record Sales, Texas Roadhouse Has Beef With Beef Costsmarketbeat.com
Texas Roadhouse posted record sales and revenue growth in Q2, but rising beef costs squeezed margins, sending shares down 19% despite a Moderate Buy analyst consensus.
Via MarketBeat · September 22, 2026
Nvidia and AMD Can't Make AI Chips Without This Growth Stock. Here's Why It Could Soar.fool.com
ASML is one of the most important companies in the AI semiconductor ecosystem.
Via The Motley Fool · September 22, 2026
Good News for S&P 500 Earnings: 86% of Companies Beat Expectations in 2026fool.com
S&P 500 companies are broadly beating analysts' estimates for earnings -- but is too much of that money riding on the AI boom?
Via The Motley Fool · September 22, 2026
Is a Fed Rate Hike Good or Bad for Stocks? You Might Be Surprised.fool.com
For the first time in more than three years, the Federal Reserve just raised interest rates.
Via The Motley Fool · September 22, 2026
Compound Interest Is the Market's Most Powerful Force: Here's How It Actually Worksfool.com
Compound interest is how your money makes money -- and it can make you rich.
Via The Motley Fool · September 22, 2026
Meta's Muse AI Is Soaring in Popularity. Could It Send the Stock to New Heights?fool.com
The hype around Meta's Muse AI assistant has investors excited that perhaps Meta's investments in AI could pay off.
Via The Motley Fool · September 22, 2026
Move Over, Tesla: This Robotics Stock Already Has Paying Customersfool.com
Symbotic is a robotics pure play, already in the commercialization stage.
Via The Motley Fool · September 22, 2026
Vertiv vs. Eaton: This AI Infrastructure Stock Is the Better Buyfool.com
Two power and cooling giants are chasing the same AI boom. But which one offers the more direct way to play it?
Via The Motley Fool · September 22, 2026
Pfizer Refocuses Growth Strategy as New Products Offset COVID Declinemarketbeat.com
Pfizer (NYSE:PFE) has rebuilt its commercial model around newer and acquired products while reducing exposure to its COVID-19 franchise, according to Alexandre de Germay, the company’s chief international commercial officer and executive vice president. Speaking with Chris Schott at a company event
Via MarketBeat · September 22, 2026
Nucor and Steel Dynamics Just Pulled Back—The Steel Story Still Looks Strongmarketbeat.com
Nucor and Steel Dynamics shares are pulling back after Q3 guidance missed estimates, but higher steel prices, strong backlogs, and wide margins support analysts' bullish price targets.
Via MarketBeat · September 22, 2026
10 Must-Have Elements of High-Performing B2B Landing Pagestalkmarkets.com
10 Must-Have Elements of High-Performing B2B Landing Pages B2B landing pages play an important role in converting campaign traffic into qualified opportuni
Via Talk Markets · September 22, 2026
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?fool.com
Semaglutide will start losing patent protection in the near future.
Via The Motley Fool · September 22, 2026
What Makes Corporate Wear for Men Look Polished Without Feeling Overdressedtalkmarkets.com
Dressing well for work does not always mean reaching for a suit, tie and highly formal shoes. Office clothing has become more flexible. But a professional
Via Talk Markets · September 22, 2026
Castor Oil Price 2026: Regional Market Trends, Supply Dynamics, and Pricing Outlooktalkmarkets.com
Castor Oil PriceCastor oil prices softened across all three major trading regions this quarter. The average castor oil price landed at approximately USD 1,
Via Talk Markets · September 22, 2026
History Says This Low-Cost Investment Could Outperform Anthropic -- and You Might Already Own Itfool.com
High-profile IPOs don't always make the best stocks to own.
Via The Motley Fool · September 22, 2026
AutoZone (NYSE:AZO) Misses Q3 CY2026 Revenue Estimates
Auto parts and accessories retailer AutoZone (NYSE:AZO) fell short of the market’s revenue expectations in Q3 CY2026, but sales rose 5.6% year on year to $6....
Via StockStory · September 22, 2026